according to The Giant Company. Flu shots for the 2024-25 flu and cold season protect individuals against three strains of ...

The pharmaceutical giant is the first company to release Phase 3 clinical trial data on a combination flu-COVID vaccine, leading the industry over rivals such as Novavax and Pfizer. “Combination ...

A person enrolled in a clinical trial receives the COVID vaccine. Employers' vaccine mandates came under scrutiny during the ...

Vaccine maker Novavax (NASDAQ: NVAX) has had a rollercoaster of a year. In May, the company's shares soared after it ...

The biopharmaceutical giant, along with its partner BioNTech ... We've just started our phase-three study of a quadrant flu vaccine made out of mRNA. We see it has several advantages over current ...

A 7,000 mile road trip from Los Angeles to Key West, Florida where some things go exactly to plan. More things do not at all ...

in a biotech firm spun out of Oxford University working on novel treatments which include a universal flu vaccine and a therapeutic cancer vaccine. The tech giant’s GV division (formerly known ...

Let's consider two examples: Vertex Pharmaceuticals (NASDAQ: VRTX) and Moderna (NASDAQ: MRNA). Here's why these biotechs are ...

the US drugs giant has said. Pfizer said it was expecting "durable demand" for the vaccine, in a similar way to flu vaccines. In the first three months of 2021, the vaccine generated revenues of $ ...

Visitors can enjoy live entertainment, giveaways, and grand prizes valued at over $1,000. Admission to the expo and ...

The biggest pharmacy benefit managers are profiting by systematically underpaying independent drugstores, creating “pharmacy deserts” across the country.

"A flu shot is a great idea for everyone ... diagonally across – a.k.a. XXL TVs – are becoming a huge hit as the cost of giant screens sinks sharply, and viewers look to replace the screens ...